盐酸新戊脒，CAS 登记号 18202-73-8，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸新戊脒 的 CAS 号：18202-73-8，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
pivalamidine hydrochloride · CAS 18202-73-8 · C5H12N2. UNII ST45027903.
| CAS Registry Number | 18202-73-8 |
|---|---|
| PubChem CID | 431752 |
| Molecular formula | C5H12N2 |
| IUPAC name | 2,2-dimethylpropanimidamide |
| UNII (FDA) | ST45027903 |
| Molecular Weight | 100.16 |
|---|---|
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 100.100048391 |
| Monoisotopic Mass | 100.100048391 |
| Topological Polar Surface Area | 49.9 |
| Heavy Atom Count | 7 |
| Formal Charge | 0 |
| Reported hazard statements | H302, H312, H332 (12.5%), H315 (100%), H319 (100%), H335 (75%) |
|---|
H302+H312+H332 (12.5%): Harmful if swallowed, in contact with skin or if inhaled [Warning Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]
H302 (12.5%): Harmful if swallowed [Warning Acute toxicity, oral]
Pivalamidine HCl; EINECS 242-091-1; NSC 297167; RefChem:863679; 242-091-1; Pivalamidine hydrochloride; 2,2-dimethylpropanimidamide; 59950-56-0; Pivalimidamide; 2,2-Dimethylpropionamidine; 2,2-dimethylpropanamidine; Propanimidamide, 2,2-dimethyl-, hydrochloride; pivalamidine; pivaloamidine; MFCD00628118; 2,2-dimethyl-propionamidine
CAS 18202-73-8; molecular formula C5H12N2; molecular weight — g/mol.
Pivalamidine HCl, EINECS 242-091-1, NSC 297167, RefChem:863679, 242-091-1, Pivalamidine hydrochloride.
Hazard statements reported: H302, H312, H332, H315, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.